Enterome
Delivering the promise of immunotherapy
France
49 employees
Venture round
Total: $175.80M
Biopharma, Biotechnology +2
General Information
France
BounceWatch is an independent company data service, not affiliated with Enterome. To contact Enterome, visit enterome.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Enterome compare?
A PDF of Enterome and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Enterome soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
France Market
Biopharma
About Enterome
Business keywords: Immunotherapy, Biopharmaceuticals, Drug Discovery, OncoMimics, Cancer Treatment, Immunomodulatory Drugs, Phase 2 Clinical Trials, Tumor Associated Antigens, CD8 T cell Response, Glioblastoma, Adrenal Malignancies, Colorectal Cancer, Clinical-stage Biotech, Immunotherapies, Metagenomics
Services & Products
Target Customers
Funding Rounds & Investors (9)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | €3.00M | 1 |
The Leukemia & Lymphoma Society’s Therapy Acceleration Program
|
30 Oct 2023 |
| Series F | €20.00M | - |
|
14 Jul 2022 |
| Series E | €46.30M | 6 |
|
25 Jun 2020 |
| Debt Financing | €40.00M | 8 |
|
04 Jan 2018 |
| Series D | €32.00M | 7 |
|
01 Jan 2017 |
| Series C | €14.50M | 5 |
|
20 Apr 2016 |
| Series B | €11.00M | 3 |
|
01 May 2014 |
| Series A | €7.50M | 4 |
|
23 Mar 2012 |
| Seed Round | €1.50M | 2 |
|
01 Jan 2011 |
Enterome Alternatives & Competitors
View All Alternatives
Pioneering immune-based therapies to harness the body's defenses against cancer through advanced imm...
Genelux Corporation (NASDAQ: GNLX) is a late clinical-stage biotechnology company focused on improvi...
Eureka Therapeutics is a privately held biotechnology company located in the San Francisco Bay Area,...
FAQ About Enterome
Source: BounceWatch company record for Enterome, https://bouncewatch.com/company/enterome, updated 7 June 2025. When citing, please name BounceWatch and link this page.
